Latest Insider Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL)
This section provides a real-time view of insider transactions for Zentalis Pharmaceuticals, Inc. (ZNTL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zentalis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zentalis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.68%
|
$1,795,198
$67.83 P/Share
|
|
Sep 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.05%
|
$670,000
$67.62 P/Share
|
|
Aug 19
2021
|
Epperly Melissa B, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,285
+3.01%
|
$430,820
$52.0 P/Share
|
|
Aug 18
2021
|
Epperly Melissa B, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,326
+0.51%
|
$68,952
$52.0 P/Share
|
|
Aug 03
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
7,779
-0.2%
|
$388,950
$50.69 P/Share
|
|
Aug 02
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.52%
|
$510,000
$51.84 P/Share
|
|
Aug 02
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-9.46%
|
$429,420
$51.75 P/Share
|
|
Aug 02
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
19,015
-0.35%
|
$969,765
$51.68 P/Share
|
|
Jul 07
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,514
-0.15%
|
$212,158
$47.04 P/Share
|
|
Jul 07
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
2,572
-0.17%
|
$120,884
$47.04 P/Share
|
|
Jul 07
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
17,804
-0.44%
|
$836,788
$47.04 P/Share
|
|
Jul 06
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,298
-0.33%
|
$954,006
$47.69 P/Share
|
|
Jul 06
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
15,798
-0.53%
|
$742,506
$47.64 P/Share
|
|
Jul 06
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
25,045
-0.6%
|
$1,177,115
$47.59 P/Share
|
|
Jul 02
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.65%
|
$490,000
$49.95 P/Share
|
|
Jul 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.47%
|
$1,366,494
$51.71 P/Share
|
|
Jul 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.3%
|
$157,233
$51.61 P/Share
|
|
Jul 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-6.84%
|
$429,420
$51.71 P/Share
|
|
Jun 04
2021
|
David Michael Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+5.06%
|
-
|
|
Jun 04
2021
|
Kimberly Blackwell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.93%
|
$1,446,876
$54.34 P/Share
|
|
Jun 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.59%
|
$166,482
$54.45 P/Share
|
|
Jun 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-10.22%
|
$454,680
$54.43 P/Share
|
|
Jun 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.95%
|
$540,000
$54.29 P/Share
|
|
May 03
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.47%
|
$580,000
$58.67 P/Share
|
|
May 03
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.29%
|
$178,814
$58.75 P/Share
|
|
May 03
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.46%
|
$1,554,052
$58.63 P/Share
|
|
May 03
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-4.41%
|
$488,360
$58.84 P/Share
|
|
Apr 21
2021
|
Anthony Y Sun President & CEO |
BUY
Bona fide gift
|
Indirect |
228,650
+50.0%
|
-
|
|
Apr 21
2021
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
228,650
-13.43%
|
-
|
|
Apr 13
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,810
-7.01%
|
$171,450
$45.0 P/Share
|
|
Apr 06
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
275
-0.03%
|
$11,825
$43.26 P/Share
|
|
Apr 06
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
165
-0.03%
|
$7,095
$43.26 P/Share
|
|
Apr 05
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
64,562
-0.61%
|
$2,840,728
$44.22 P/Share
|
|
Apr 05
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
400
-0.73%
|
$18,000
$45.07 P/Share
|
|
Apr 05
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
24,536
-0.59%
|
$1,079,584
$44.0 P/Share
|
|
Apr 05
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,107
-1.52%
|
$752,708
$44.02 P/Share
|
|
Apr 05
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
28,204
-1.26%
|
$1,240,976
$44.01 P/Share
|
|
Apr 05
2021
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,897
-12.67%
|
$554,571
$43.5 P/Share
|
|
Apr 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-2.43%
|
$181,030
$43.96 P/Share
|
|
Mar 10
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,720
-7.41%
|
$212,400
$45.24 P/Share
|
|
Mar 03
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,700
-5.49%
|
$166,500
$45.07 P/Share
|
|
Mar 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-1.08%
|
$126,403
$41.67 P/Share
|
|
Mar 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.74%
|
$410,000
$41.69 P/Share
|
|
Mar 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.75%
|
$1,098,554
$41.53 P/Share
|
|
Mar 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-5.88%
|
$172,610
$41.65 P/Share
|
|
Feb 11
2021
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+1.19%
|
-
|
|
Feb 11
2021
|
Dimitris Voliotis SVP, Clinical Development |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+50.0%
|
-
|
|
Feb 11
2021
|
Anthony Y Sun President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+2.38%
|
-
|
|
Feb 11
2021
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+1.76%
|
-
|